AllFreePapers.com - All Free Papers and Essays for All Students
Search

Swot Analysis of Pharmcare

Autor:   •  May 30, 2012  •  Case Study  •  1,019 Words (5 Pages)  •  3,160 Views

Page 1 of 5

Question 1

What does the SWOT analysis tell us about the competitive position of Pharmcare with the industry as a whole?

From the illustration, Pharmcare strengths include its flexible salesforce, economies of scale, strong brand name and health care education department.

From the illustration, it shows that the flexible salesforce can cope with the environmental change as all of the four categories have positive score. The score of the health care rationing is +3, complex and changing buying structures is +5, increased integration of health care is +2 and informed patients is +2.

The economies of scale is another strengths of Pharmcare. This helps Pharmcare to cope with the environmental change as two of the categories have positive score. The score of the increased integration of health care is +3 and informed patients is +3.

The strong brand name is another strengths of Pharmcare. This helps Pharmcare to cope with the environmental change as two of the categories have positive score. The score of health care rationing is +2, complex and changing buying structures is +1. However, the score of informed patients is -1.

The health care education department is another strengths of Pharmcare. This helps Pharmcare to cope with the environmental change as four of the categories have positive score. The score of health care rationing is +4, complex and changing buying structures is +3, increased integration of health care is +4 and informed patients is +5.

Pharmcare’s weaknesses includes limitied competences in biotechnology and genetics, ever lower R&D productivity, weak ICT competences and over-reliance on leading product.

Limited competences in biotechnology and genetics is one of the weaknesses when Pharmcare faces environmental change as two of the categories have negative score. The score of increased integration of health care is -4 and informed patients is -3.

Ever lower R&D productivity is another weakness when Pharmcare faces environmental change as four of the categories have negative score. The score of health care rationing is -3, complex and changing buying structures is -2, increased integration of health care is -1 and informed patients is -2.

The weak ICT competences is another weakness of Pharmcare when faces environmental change as four of the categories have negative score. The score of health care rationing is -2, complex and changing buying structures is -2, increased integration of health care is -5 and informed patients is -5.

Over-reliance on leading product is another weakness of Pharmcare when faces the environmental change as four of the categories have negative score. The score of health care rationing is -1, complex and changing buying structures is -1, increased integration

...

Download as:   txt (6.4 Kb)   pdf (120.6 Kb)   docx (11.8 Kb)  
Continue for 4 more pages »